Home
Clinical Resources Search
PQI: Toripalimab (Loqtorzi®) for Recurrent or Metastatic Nasopharyngeal Carcinoma

Toripalimab (Loqtorzi®) for Recurrent or Metastatic Nasopharyngeal Carcinoma

Last Updated: December 5, 2024

By: Shirin Khorashadi, PharmD, BCOP | Deborah J. Wong, MD, PhD | Hyu Kang, MD, MPH, FACP

About this PQI

The purpose of this PQI is to discuss clinical considerations for the use of toripalimab (Loqtorzi®) for treatment of recurrent, locally advanced nasopharyngeal carcinoma or metastatic nasopharyngeal carcinoma (RM-NPC).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Toripalimab (Loqtorzi®) for Recurrent or Metastatic Nasopharyngeal Carcinoma

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia

PQI: Datopotamab deruxtecan (Datroway): Prophylaxis and Management of Adverse Events

PQI: Streamlining Enrollment in the Medicare Prescription Payment Plan (MPPP)

PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers

PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

PQI in Action: Abiraterone acetate (Yonsa) Patient Selection and Management

S9 E15: Theranostics: The New Era of Targeted Imaging & Therapy

S9 E14: Immunotherapy and the MyMelanoma Project

S9 E13: A Season of Gratitude

S9 E12: “We Won the Battle, Now Let’s Paddle”

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Bispecific Antibody

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Penpulimab, Gemcitabine, and Cisplatin

Penpulimab, Gemcitabine, and Carboplatin

Nivolumab and Hyaluronidase

Toripalimab

Penpulimab, Gemcitabine, and Carboplatin

Toripalimab

Toripalimab

Toripalimab

S9 E15: Theranostics: The New Era of Targeted Imaging & Therapy

PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers

Abiraterone and Prednisone

Abiraterone (Micronized Formulation) and Methylprednisolone